SCHEMBL8790243

SCHEMBL8790243

COc1cc(OC)c2[nH]c3c(C(=O)Nc4ccc(CCN(C)Cc5ccc(OC)c(OC)c5)cc4)cccc3c(=O)c2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCG2 Q9UNQ0 6/20 0.55
▸ ABCB1 P08183 3/20 0.55
▸ MAPT P10636 2/20 0.46
▸ TP53 P04637 2/20 0.42
▸ BCHE P06276 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ OPRM1 P35372 2/20 0.41
▸ TMEM97 Q5BJF2 2/20 0.41
▸ SIGMAR1 Q99720 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ OPRK1 P41145 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ ROCK2 O75116 1/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8789648 0.93 ABCG2 (0.63) ABCG2ABCB1MAPTTP53BCHE
SCHEMBL8789264 0.90 ABCG2 (0.55) ABCG2ABCB1MAPTTP53BCHE
SCHEMBL8789595 0.89 ABCG2 (0.54) ABCG2ABCB1MAPTBCHEACHE
SCHEMBL8790168 0.89 ABCG2 (0.62) ABCG2ABCB1MAPTTP53BCHE
SCHEMBL8789736 0.88 ABCG2 (0.55) ABCG2ABCB1MAPTTP53BCHE
SCHEMBL8789541 0.88 ABCG2 (0.65) ABCG2ABCB1MAPTBCHEACHE
SCHEMBL8789486 0.88 ABCG2 (0.61) ABCG2ABCB1MAPTTP53BCHE
SCHEMBL8789457 0.88 ABCG2 (0.60) ABCG2ABCB1MAPTTP53BCHE
SCHEMBL8789662 0.88 ABCG2 (0.64) ABCG2ABCB1MAPTTP53ALDH1A1
SCHEMBL8789696 0.88 ABCG2 (0.53) ABCG2ABCB1MAPTBCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0569380-B1 ACRIDINE DERIVATIVES GLAXO LAB SA (FR) 1997-05-28 — — EP disclosed
US-5604237-A IMPROVE OR INCREASE EFFICACY OF ANTITUMOR AGENT, INCREASE OR RESTORE SENSITIVITY OF TUMOR TO ANTITUMOR AGENT, REVERSE OR REDUCE RESISTANCE OF TUMOR TO ANTITUMOR AGENT LABORATOIRES GLAXO SA (FR) 1997-02-18 — — US disclosed
EP-0494623-A1 Acridine derivatives LABORATOIRES GLAXO SA (FR) 1992-07-15 — — EP disclosed
Send feedback